Terms: = Lymphoma AND LMO2, RBTN2, 4005, ENSG00000135363, P25791, TTG2, RBTNL1, RHOM2 AND Treatment
16 results:
1. ZNF683 marks a CD8
Parry EM; Lemvigh CK; Deng S; Dangle N; Ruthen N; Knisbacher BA; Broséus J; Hergalant S; Guièze R; Li S; Zhang W; Johnson C; Long JM; Yin S; Werner L; Anandappa A; Purroy N; Gohil S; Oliveira G; Bachireddy P; Shukla SA; Huang T; Khoury JD; Thakral B; Dickinson M; Tam C; Livak KJ; Getz G; Neuberg D; Feugier P; Kharchenko P; Wierda W; Olsen LR; Jain N; Wu CJ
Cancer Cell; 2023 Oct; 41(10):1803-1816.e8. PubMed ID: 37738974
[TBL] [Abstract] [Full Text] [Related]
2. PARP inhibitor exerts an anti-tumor effect via lmo2 and synergizes with cisplatin in natural killer/T cell lymphoma.
Wu J; Shi C; Li H; Song W; Huang S; Zhang J; Li W; Li Z; Zhang M
BMC Med; 2023 Jul; 21(1):253. PubMed ID: 37442994
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia.
Kumari S; Ali MS; Singh J; Arora M; Verma D; Pandey AK; Benjamin M; Bakhshi S; Palanichamy JK; Sharma A; Singh I; Tanwar P; Singh AR; Pushpam D; Qamar I; Chopra A
Hematol Oncol; 2022 Oct; 40(4):577-587. PubMed ID: 35644022
[TBL] [Abstract] [Full Text] [Related]
4. lmo2 Confers Synthetic Lethality to PARP Inhibition in DLBCL.
Parvin S; Ramirez-Labrada A; Aumann S; Lu X; Weich N; Santiago G; Cortizas EM; Sharabi E; Zhang Y; Sanchez-Garcia I; Gentles AJ; Roberts E; Bilbao-Cortes D; Vega F; Chapman JR; Verdun RE; Lossos IS
Cancer Cell; 2019 Sep; 36(3):237-249.e6. PubMed ID: 31447348
[TBL] [Abstract] [Full Text] [Related]
5. PI3Kγ/δ and NOTCH1 Cross-Regulate Pathways That Define the T-cell Acute Lymphoblastic Leukemia Disease Signature.
Efimenko E; Davé UP; Lebedeva IV; Shen Y; Sanchez-Quintero MJ; Diolaiti D; Kung A; Lannutti BJ; Chen J; Realubit R; Niatsetskaya Z; Ten V; Karan C; Chen X; Califano A; Diacovo TG
Mol Cancer Ther; 2017 Oct; 16(10):2069-2082. PubMed ID: 28716817
[TBL] [Abstract] [Full Text] [Related]
6. High concordance of gene expression profiling-correlated immunohistochemistry algorithms in diffuse large B-cell lymphoma, not otherwise specified.
Hwang HS; Park CS; Yoon DH; Suh C; Huh J
Am J Surg Pathol; 2014 Aug; 38(8):1046-57. PubMed ID: 24705314
[TBL] [Abstract] [Full Text] [Related]
7. LIM domain only-2 (lmo2) induces T-cell leukemia by two distinct pathways.
Smith S; Tripathi R; Goodings C; Cleveland S; Mathias E; Hardaway JA; Elliott N; Yi Y; Chen X; Downing J; Mullighan C; Swing DA; Tessarollo L; Li L; Love P; Jenkins NA; Copeland NG; Thompson MA; Du Y; Davé UP
PLoS One; 2014; 9(1):e85883. PubMed ID: 24465765
[TBL] [Abstract] [Full Text] [Related]
8. Tissue microarray in a subset of South African patients with DLBCL.
Sissolak G; Wood L; Smith L; Chan JW; Armitage J; Jacobs P
Transfus Apher Sci; 2013 Oct; 49(2):120-32. PubMed ID: 23942329
[TBL] [Abstract] [Full Text] [Related]
9. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/lmo2 mouse model of T-ALL.
Tatarek J; Cullion K; Ashworth T; Gerstein R; Aster JC; Kelliher MA
Blood; 2011 Aug; 118(6):1579-90. PubMed ID: 21670468
[TBL] [Abstract] [Full Text] [Related]
10. NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols.
Zuurbier L; Homminga I; Calvert V; te Winkel ML; Buijs-Gladdines JG; Kooi C; Smits WK; Sonneveld E; Veerman AJ; Kamps WA; Horstmann M; Petricoin EF; Pieters R; Meijerink JP
Leukemia; 2010 Dec; 24(12):2014-22. PubMed ID: 20861909
[TBL] [Abstract] [Full Text] [Related]
11. Extracellular tumor-related mRNA in plasma of lymphoma patients and survival implications.
Garcia V; Garcia JM; Silva J; Martin P; Peña C; Dominguez G; Diaz R; Herrera M; Maximiano C; Sabin P; Rueda A; Cruz MA; Rodriguez J; Canales MA; Bonilla F; Provencio M
PLoS One; 2009 Dec; 4(12):e8173. PubMed ID: 20016842
[TBL] [Abstract] [Full Text] [Related]
12. The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab.
Jais JP; Haioun C; Molina TJ; Rickman DS; de Reynies A; Berger F; Gisselbrecht C; Brière J; Reyes F; Gaulard P; Feugier P; Labouyrie E; Tilly H; Bastard C; Coiffier B; Salles G; Leroy K;
Leukemia; 2008 Oct; 22(10):1917-24. PubMed ID: 18615101
[TBL] [Abstract] [Full Text] [Related]
13. Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and adolescents: a report from CCG-E08.
Lones MA; Heerema NA; Le Beau MM; Sposto R; Perkins SL; Kadin ME; Kjeldsberg CR; Meadows A; Siegel S; Buckley J; Abromowitch M; Kersey J; Bergeron S; Cairo MS; Sanger WG
Cancer Genet Cytogenet; 2007 Jan; 172(1):1-11. PubMed ID: 17175373
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
Ferrando AA; Neuberg DS; Dodge RK; Paietta E; Larson RA; Wiernik PH; Rowe JM; Caligiuri MA; Bloomfield CD; Look AT
Lancet; 2004 Feb; 363(9408):535-6. PubMed ID: 14975618
[TBL] [Abstract] [Full Text] [Related]
15. Gene expression profiling in T-cell acute lymphoblastic leukemia.
Ferrando AA; Look AT
Semin Hematol; 2003 Oct; 40(4):274-80. PubMed ID: 14582078
[TBL] [Abstract] [Full Text] [Related]
16. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.
Ferrando AA; Neuberg DS; Staunton J; Loh ML; Huard C; Raimondi SC; Behm FG; Pui CH; Downing JR; Gilliland DG; Lander ES; Golub TR; Look AT
Cancer Cell; 2002 Feb; 1(1):75-87. PubMed ID: 12086890
[TBL] [Abstract] [Full Text] [Related]
